p.Ser1235Arg should no longer be considered as a Cystic Fibrosis mutation: results from a large collaborative study - Université de Rennes Accéder directement au contenu
Article Dans Une Revue European Journal of Human Genetics Année : 2010

p.Ser1235Arg should no longer be considered as a Cystic Fibrosis mutation: results from a large collaborative study

Emmanuelle Girodon
Hervé Mittre

Résumé

Among the 1700 mutations reported in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, a missense mutation, p.Ser1235Arg, initially reported in a CF patient with a second mutation (p.Gly628Arg) on the same allele, is a relatively frequent finding. To clarify its clinical significance, we collected data from 104 subjects heterozygous for the mutation p.Ser1235Arg from the French CF network, addressed for various indications including classical CF, atypical phenotypes or carrier screening in subjects with or without a family history. Among them, twenty-six patients (five having CF, ten CBAVD -Congenital Absence of the Vas Deferens- and eleven with CF-like symptoms) and fourteen healthy subjects were compound heterozygous for a second CFTR mutation. An exhaustive CFTR gene analysis identified a second mutation in cis of p.Ser1235Arg in all CF patients and in 81.8% CBAVD patients. Moreover, epidemiological data from more than 2100 individuals found a higher frequency of p.Ser1235Arg in the general population than in CF or CBAVD patients. These data, added to the fact that in silico analysis and functional assays suggest a benign nature of this substitution gives several lines of evidence against an association of p.Ser1235Arg with CF or CBAVD.
Fichier principal
Vignette du fichier
PEER_stage2_10.1038%2Fejhg.2010.137.pdf (1.3 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00567037 , version 1 (18-02-2011)

Identifiants

Citer

Celine Rene, Damien Paulet, Emmanuelle Girodon, Catherine Costa, Guy Lalau, et al.. p.Ser1235Arg should no longer be considered as a Cystic Fibrosis mutation: results from a large collaborative study: p.Ser1235Arg is not associated with CF disease. European Journal of Human Genetics, 2010, ⟨10.1038/ejhg.2010.137⟩. ⟨hal-00567037⟩
280 Consultations
171 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More